| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| GSK3145095 |
|
1622849-43-7 |
詳細(xì)
|
| AHR antagonist 1 |
|
2162982-11-6 |
詳細(xì)
|
| (3S)-3-amino-2-hydroxy-5-methylhexanoicacid |
|
318464-20-9 |
詳細(xì)
|
| (Alphas)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate) |
(Alphas)-alpha-氨基苯丁?；?L-亮氨?；?L-苯丙氨酸甲酯單(三氟乙酸鹽) |
868539-99-5 |
詳細(xì)
|
| mAChR-IN-1 |
|
119391-56-9 |
詳細(xì)
|
| SRI-31215 Bis-TFA salt |
|
1832686-44-8 |
詳細(xì)
|
| Guanabenz |
氯壓胍 |
5051-62-7 |
詳細(xì)
|
| Glumetinib |
|
1642581-63-2 |
詳細(xì)
|
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2R)-,monomethanesulfonate |
|
856865-74-2 |
詳細(xì)
|
| (R)-5-Fluoro-2-methoxy-3-(pyrrolidin-2-yl)pyridine dihydrochloride |
|
1260845-81-5 |
詳細(xì)
|
| D159687 |
|
1155877-97-6 |
詳細(xì)
|
| Tyrosine kinase-IN-1 |
|
705946-27-6 |
詳細(xì)
|
| FITM |
|
932737-65-0 |
詳細(xì)
|
| BTSA 1 |
|
314761-14-3 |
詳細(xì)
|
| Deferasirox Impurity 2 |
地拉羅斯雜質(zhì)2 |
1395346-29-8 |
詳細(xì)
|
| CAY10594 |
|
1130067-34-3 |
詳細(xì)
|
| 2-Amino-N,3-dimethylbenzamide |
2-氨基-N,3-二甲基苯甲酰胺 |
870997-57-2 |
詳細(xì)
|
| GSK2894631A |
|
2101626-26-8 |
詳細(xì)
|
| Dihydrogen dinitrosulfatoplatinate(II) |
二硝基硫酸二氫化鉑(II)溶液， Pd 46% w/v (cont. Pd) |
12033-81-7 |
詳細(xì)
|
| Tert-butyl 4-chlorobutanoate |
4-氯丁酸叔丁酯 |
3153-32-0 |
詳細(xì)
|
| GDC0575 hydrochloride |
|
1196504-54-7 |
詳細(xì)
|
| 1-Ethylnaphthalene |
1-乙基萘 |
1127-76-0 |
詳細(xì)
|
| Clofarabine Impurity 1 |
氯法拉濱雜質(zhì)1 |
704916-12-1 |
詳細(xì)
|
| IRAK inhibitor 1 |
環(huán)巴胺抑制劑 1 |
1042224-63-4 |
詳細(xì)
|
| MW-150 dihydrochloride dihydrate |
|
1661020-92-3 |
詳細(xì)
|
| 3,5-Dimethylcyclohexanol |
3,5-二甲基己醇 |
5441-52-1 |
詳細(xì)
|
| Methyl 5-chloro-6-fluoronicotinate |
|
1171918-85-6 |
詳細(xì)
|
| DLin-KC2-DMA |
|
1190197-97-7 |
詳細(xì)
|
| 4-tert-Butylcyclohexanol |
4-叔丁基環(huán)己醇 |
98-52-2 |
詳細(xì)
|
| MK-0731 |
|
845256-65-7 |
詳細(xì)
|
| 4-Isopropylcyclohexanone |
4-異丙基環(huán)己酮 |
5432-85-9 |
詳細(xì)
|
| 1-Methyl-7-nitroisatoic anhydride |
|
73043-80-8 |
詳細(xì)
|
| MC180295 |
|
2237942-08-2 |
詳細(xì)
|
| 2-Amino-4-chlorobenzoic acid |
2-氨基-4-氯苯甲酸 |
89-77-0 |
詳細(xì)
|
| Methyl 8-(tert-butyl)-6-chloroimidazo[1,2-b]pyridazine-2-carboxylate |
8-(叔丁基)-6-氯咪唑并[1,2-B]吡啶-2-羧酸甲酯 |
1690176-75-0 |
詳細(xì)
|
| SEL120-34A |
|
1609522-33-9 |
詳細(xì)
|
| LOXO-101 HCl salt |
|
1919868-83-9 |
詳細(xì)
|
| DC661 |
|
1872387-43-3 |
詳細(xì)
|
| Canakinumab |
卡那津單抗 |
914613-48-2 |
詳細(xì)
|
| SMAP |
|
1809427-19-7 |
詳細(xì)
|
| N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-YL)pyridin-2-YL)cyclopropanecarboxamide |
|
1286230-87-2 |
詳細(xì)
|
| eFT508 HCl |
|
1849590-02-8 |
詳細(xì)
|
| BI-4464 |
|
1227948-02-8 |
詳細(xì)
|
| Apelin-36 (rat, mouse) |
愛帕琳肽 |
230299-95-3 |
詳細(xì)
|
| Sulfalen |
|
152-47-6 |
詳細(xì)
|
| Remetinostat |
|
946150-57-8 |
詳細(xì)
|
| Fosaprepitant Impurity 31 |
阿瑞匹坦雜質(zhì)12 |
1185503-48-3 |
詳細(xì)
|
| EF-5 |
|
152721-37-4 |
詳細(xì)
|
| 2-Methyl-Celecoxib |
塞來昔布雜質(zhì)7 |
170570-09-9 |
詳細(xì)
|
| GDP366 |
|
501698-03-9 |
詳細(xì)
|
| ON-579 |
|
141286-14-8 |
詳細(xì)
|
| AWZ1066S |
|
2239272-16-1 |
詳細(xì)
|
| STING agonist-3 |
|
2138299-29-1 |
詳細(xì)
|
| Rocaglamide |
|
84573-16-0 |
詳細(xì)
|
| diABZI STING agonist-1 trihydrochloride |
|
2138299-34-8 |
詳細(xì)
|
| V-9302 |
|
1855871-76-9 |
詳細(xì)
|
| 2'-Nitro-5'-hydroxyacetophenone |
2-硝基-5-羥基苯乙酮 |
30879-49-3 |
詳細(xì)
|
| 4-Aminoacetophenone |
4-氨基苯乙酮 |
99-92-3 |
詳細(xì)
|
| Ethyl 4-hydroxy-2-(pyridin-3-yl)thiazole-5-carboxylate |
|
1232031-84-3 |
詳細(xì)
|
| ATI-2341 |
|
1337878-62-2 |
詳細(xì)
|
| Leniolisib |
|
1354690-24-6 |
詳細(xì)
|
| Trastuzumab emtansine |
曲妥珠單抗-Emtansine偶聯(lián)物 |
1018448-65-1 |
詳細(xì)
|
| NSC228155 |
|
113104-25-9 |
詳細(xì)
|
| (+)-JQ1 PA |
|
2115701-93-2 |
詳細(xì)
|
| C25-140 |
|
1358099-18-9 |
詳細(xì)
|
| GGTI-2418 |
|
501010-06-6 |
詳細(xì)
|
| Adavivint |
|
1467093-03-3 |
詳細(xì)
|
| JQEZ5 |
|
1913252-04-6 |
詳細(xì)
|
| DAG |
3,4-二氨基乙二肟 |
2580-79-2 |
詳細(xì)
|
| INCB054329 |
|
1628607-64-6 |
詳細(xì)
|
| BRD4 degrader AT1 |
|
2098836-45-2 |
詳細(xì)
|
| BAY-545 |
|
1699717-32-2 |
詳細(xì)
|
| Belimumab |
貝利木單抗 |
356547-88-1 |
詳細(xì)
|
| Golimumab |
戈利木單抗 |
476181-74-5 |
詳細(xì)
|
| Fiboflapon Sodium |
|
1196070-26-4 |
詳細(xì)
|
| Necitumumab |
耐昔妥珠單抗 |
906805-06-9 |
詳細(xì)
|
| Dl-3-pyrrolidinol |
吡咯烷醇 |
83220-72-8 |
詳細(xì)
|
| CID-1375606 |
|
313493-80-0 |
詳細(xì)
|
| VL285 |
|
1448188-57-5 |
詳細(xì)
|
| BIBF0775 |
|
334951-90-5 |
詳細(xì)
|
| SAR348830 |
|
1462949-64-9 |
詳細(xì)
|
| IDH-305 |
|
1628805-46-8 |
詳細(xì)
|
| Tafamidis meglumine |
|
951395-08-7 |
詳細(xì)
|
| MOPIPP |
|
1485521-76-3 |
詳細(xì)
|
| SPHINX31 |
|
1818389-84-2 |
詳細(xì)
|
| Efmoroctocog Alfa |
艾莫凝血素-8a |
1270012-79-7 |
詳細(xì)
|
| MA-0204 |
|
2095128-17-7 |
詳細(xì)
|
| RK-287107 |
|
2171386-10-8 |
詳細(xì)
|
| Pirozadil |
吡扎地爾 |
54110-25-7 |
詳細(xì)
|
| 5-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde |
|
1314734-59-2 |
詳細(xì)
|
| D-Lin-MC3-DMA |
|
1224606-06-7 |
詳細(xì)
|
| PZ-2891 |
|
2170608-82-7 |
詳細(xì)
|
| PWT143 |
|
1595129-71-7 |
詳細(xì)
|
| UVI3003 |
|
847239-17-2 |
詳細(xì)
|
| Verdiperstat |
|
890655-80-8 |
詳細(xì)
|
| Corin |
|
1808113-09-8 |
詳細(xì)
|
| Olaratumab |
奧拉單抗 |
1024603-93-7 |
詳細(xì)
|
| Tetraammineplatinum(II) hydrogen phosphate |
四氨合磷酸氫鉑 |
127733-98-6 |
詳細(xì)
|
| 666-15 |
|
1433286-70-4 |
詳細(xì)
|
| 5-Methoxy-2-methylpyrimidine |
2-甲基-5-甲氧基嘧啶 |
1782399-94-3 |
詳細(xì)
|